UTAH MEDICAL PRODUCTS, INC. AND SUBSIDIARIES CONSOLIDATED CONDENSED STATEMENTS OF CASH FLOWS (USD $) In Thousands	9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Net income	$ 5,556	$ 4,505
Depreciation	536	416
Amortization	1,424	33
(Gain) loss on investments	(6)	(39)
Provision for (recovery of) losses on accounts receivable	10	4
Deferred income taxes	(374)
(Gain) loss on disposal of assets		0
Stock-based compensation expense	73	64
Accounts receivable - trade	287	303
Accrued interest and other receivables	(26)	(45)
Inventories	(579)	122
Prepaid expenses and other current assets	163	48
Accounts payable	(439)	21
Accrued expenses	955	55
Deferred revenue	(52)
Other liability	330
Total adjustments	2,303	982
Net cash provided by operating activities	7,859	5,487
Capital expenditures for property and equipment	(196)	(1,418)
Capital expenditures for intangible assets	(8)	(2)
Purchases of investments	(500)	(1,200)
Proceeds from sale of investments	15,155	2,639
Net cash paid in acquisition	(41,084)
Net cash provided by (used in) investing activities	(26,633)	19
Proceeds from issuance of common stock - options	442	380
Common stock purchased and retired		(439)
Tax benefit attributable to exercise of stock options	30	30
Proceeds from notes payable	26,934
Repayments of note payable	(3,682)	(302)
Payment of dividends	(1,705)	(1,707)
Net cash provided by (used in) financing activities	22,019	(2,037)
Effect of exchange rate changes on cash	(23)	(28)
NET INCREASE (DECREASE) IN CASH	3,222	3,441
CASH AT BEGINNING OF PERIOD	3,818	410
CASH AT END OF PERIOD	7,040	3,851
Cash paid during the period for income taxes	2,015	2,055
Cash paid during the period for interest	$ 636	$ 19